Product Details for: Survanta

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Suspension
Intratracheal
100MG/4ML (25MG/ML)
Single-Dose Vial
351(a)
Survanta
Rx
002
Suspension
Intratracheal
200MG/8ML (25MG/ML)
Single-Dose Vial
351(a)
Survanta
Rx
Proper Name
beractant
BLA Number
020032
Applicant
AbbVie Inc.
Original Approval Date
July 1, 1991
Date of First Licensure
RETURN TO SEARCH RESULTS